$1.43
▼ -0.7% Today
as of Jul 22, 16:46 ET
Last 30 days
Recent Press Releases & News
Autolus Therapeutics (AUTL) Grants Inducement Awards to New Employees
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Autolus Therapeutics to Participate in Upcoming Investor Conference
Overview
52-week range
$1.18
$2.70
17% of range
Avg surprise (last 3)
+7.9%
Avg reaction (last 2)
+1.4%
50% positive
Latest IV / EM
391%
EM ±16.3% · $2 · Jun 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.27 | $-0.29 | +6.9% | -3.9% | -7.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.30 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.18 | $-0.24 | +25.0% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.26 | $-0.24 | -8.3% | — | +9.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.31 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.22 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.24 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.26 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.26 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$0.28 | -$0.18 | -55.6% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $9M | — | — | — |
| Cost of revenue | $25M | — | $29M | $24M | $18M | — | $0 | $0 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-60M | — | $-72M | $-61M | $-65M | — | $-68M | $-59M |
| Net income | $-72M | — | $-79M | $-48M | $-70M | — | $-82M | $-58M |
| EPS (diluted) | $-0.27 | — | $-0.30 | $-0.18 | $-0.26 | — | $-0.31 | $-0.22 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $131M | $104M | $86M | $124M | $96M | $227M | $657M | $706M |
| Inventory | $33M | $33M | $28M | $24M | $15M | $4M | — | — |
| Total current assets | $369M | $436M | $515M | $574M | $616M | $661M | $718M | $759M |
| Total assets | $527M | $589M | $662M | $721M | $746M | $783M | $827M | $854M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $418M | $411M | $396M | $375M | $375M | $355M | $351M | $326M |
| Total equity | $109M | $178M | $265M | $346M | $371M | $427M | $477M | $528M |